OPGN (opgen.com) רווח נקי למניה (EPS TTM)

OpGen, Inc. (OPGN) generates revenue through long-term supplies of cartridges for its molecular tests. The rolling net income per share snapshot provided by the GURU.Markets website visualizes the dynamics of this process, where -40.23 characterizes this valuation parameter. Fundamentally, the business relies on partnerships with CDMO vendors, yet it faces a liquidity shortage and the threat of delisting.

Net income per share over 12 months determines the real efficiency of capital generation, excluding the impact of securities issuance. By analyzing the EPS TTM fundamental indicator, an investor sees the ratio of final income to the total number of shares. This metric allows one to separate market volatility from actual financial growth. For OpGen, Inc. (OPGN), a critical liquidity deficit makes this indicator a key marker of survival. Negative dynamics here confirm competitor pressure and the slow implementation of diagnostic tests.